Matches in Nanopublications for { ?s ?p "[RyR2 cardiac Ca(2+) release channel inhibition appears to determine efficacy of class I drugs for the prevention of CPVT in Casq2(-/-) mice.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 3 of
3
with 100 items per page.
- assertion description "[RyR2 cardiac Ca(2+) release channel inhibition appears to determine efficacy of class I drugs for the prevention of CPVT in Casq2(-/-) mice.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP282632.RAaZqF5qmzytxAH0BECcx-Xz6cwNkj5IwCLQAWS8F4dEw130_assertion description "[RyR2 cardiac Ca(2+) release channel inhibition appears to determine efficacy of class I drugs for the prevention of CPVT in Casq2(-/-) mice.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP282632.RAaZqF5qmzytxAH0BECcx-Xz6cwNkj5IwCLQAWS8F4dEw130_provenance.
- NP867977.RAO9zulU0ZfoBRCdGYJv76DXXwnFdqxRcjwCN_UoRRpOc130_assertion description "[RyR2 cardiac Ca(2+) release channel inhibition appears to determine efficacy of class I drugs for the prevention of CPVT in Casq2(-/-) mice.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP867977.RAO9zulU0ZfoBRCdGYJv76DXXwnFdqxRcjwCN_UoRRpOc130_provenance.